Fresh, sourced stories worth posting about for venture capitalists — updated every few hours, with the receipts attached. Not generated guesses.
Your desk is ready
Free to start · no card required · your pick is waiting on the other side.
Niche's weekly rollup — one email, no spam.
The stories refresh every few hours from live news and primary sources. Each carries the publisher and the date it was published — so you can see exactly how current it is.
Real reporting and primary filings — every story links its sources. Nothing here is a generated guess; the angle is identified and the receipts are attached.
Yes. These are starting points for your own posts. Draft one and Niche writes it in your voice, platform-native, ready to publish.
A cluster of clinical updates shows multiple sponsored programs moving through active, recruiting, or completed stages across hypertension, obesity, sleep apnea, diabetes, psoriasis, Alzheimer’s, celiac disease, and related indications. These signals collectively reflect continued de-risking of therapeutic platforms and a steady clinical cadence for venture-linked life sciences.
Draft a post from this →The conversation about equity for a senior hire at a $1B valuation with $300M raised, plus a physician-CMO equity discussion, captures a recurring venture theme: how much ownership and cash is enough once startups move from pre-seed into scale-up territory.
Draft a post from this →A set of trials and grants points to application-layer innovation in mobile driving safety, obstetrical tracking sensors, telerobotics, imaging platforms, and longitudinal biomarker studies. The common thread is productizable research that could inform new healthtech, medtech, or applied AI startups.
Draft a post from this →NIH awards to organizations and university teams point to research programs with commercialization potential in imaging, AI-enabled screening, neurovascular robotics, opioid intervention research, and translational infrastructure. For venture audiences, this is the upstream innovation pipeline where future startups and spinouts often emerge.
Draft a post from this →